Critical Care

official impact factor 4.60

Bench-to-bedside review: The role of activated protein C in maintaining endothelial tight junction function and its relationship to organ injury

Mark R Looney* and Michael A Matthay

Critical Care 2006, 10:239 doi:10.1186/cc5099

Accesses  

  • Last 30 days: 14 accesses
  • Last year: 334 accesses
  • All time: 2802 accesses

Cited by

BioMed Central: 4 citations

Commentary   Free

Inhaled activated protein C: a novel therapy for acute lung injury?

Kathleen D Liu, Mark R Looney, Michael A Matthay Critical Care 2009, 13:150 (21 May 2009)

Research   Open Access Highly Accessed

Early drotrecogin alpha (activated) administration in severe sepsis is associated with lower mortality: a retrospective analysis of the Canadian ENHANCE cohort

Richard V Hodder, Richard Hall, James A Russell, Harold N Fisher, Bobbie Lee Critical Care 2009, 13:R78 (20 May 2009)

Letter   Free

To be or not to be protease activated receptor-1 in activated protein C-initiated endothelial barrier protection?

Shi-Sheng Li Critical Care 2007, 11:407 (19 February 2007)

Commentary   Free

Recombinant activated protein C in sepsis: endothelium protection or endothelium therapy?

Veronique Regnault, Bruno Levy Critical Care 2006, 11:103 (11 January 2007)